Vaxcyte, Inc. (PCVX) Discusses Top Line Results From OPUS-1 Phase 3 Trial of VAX-31 Pneumococcal Vaccine Candidate - Slideshow (NASDAQ:PCVX) 2026-10-05
· seekingalpha.com
2026-10-05. The following slide deck was published by Vaxcyte, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...